Cost-Effectiveness of First-Line Tyrosine Kinase Inhibitor Therapy Initiation Strategies for Chronic Myeloid Leukemia (vol 23, pg 1292, 2020)

Nguyen J. T.; Cole A. L.; Leech A. A.Wood W. A.Dusetzina S. B.

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Cost-Effectiveness of First-Line Tyrosine Kinase Inhibitor Therapy Initiation Strategies for Chronic Myeloid Leukemia (vol 23, pg 1292, 2020)

【24h】

Cost-Effectiveness of First-Line Tyrosine Kinase Inhibitor Therapy Initiation Strategies for Chronic Myeloid Leukemia (vol 23, pg 1292, 2020)

机译：一线酪氨酸激酶的成本效益抑制剂治疗启动策略慢性粒细胞白血病(23卷,1292 pg, 2020)

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research 》 |2020年第12期| 1671-1671| 共1页
作者
Nguyen J. T.; Cole A. L.; Leech A. A.Wood W. A.Dusetzina S. B.;
展开▼
作者单位

Univ N Carolina, Eshelman Sch Pharm, Div Pharmaceut Outcomes & Policy, Chapel Hill, NC 27515 USA;

Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA;

Univ N Carolina, Sch Med, Div Hematol & Oncol, Chapel Hill, NC 27515 USA;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类
关键词

相似文献

外文文献
中文文献

1. Monitoring and Analysis of Chinese Chronic Myeloid Leukemia Patients Who Have Stopped Tyrosine Kinase Inhibitor Therapy [J] . Na SHEN, Yong YOU, Zhao-dong ZHONG, 当代医学科学(英文) . 2019 ,第002期
2. Immediate Versus Delayed Treatment with EGFR Tyrosine Kinase Inhibitors after First-line Therapy in Advanced Non-small-cell Lung Cancer [J] . Zhi-jie Wang, Tong-tong An, Tony Mok, 中国癌症研究：英文版 . 2011 ,第002期
3. Immediate Versus Delayed Treatment with EGFR Tyrosine Kinase Inhibitors after First-line Therapy in Advanced Non-small-cell Lung Cancer [J] . Zhi-jie Wang, Ping-ping Li, Hong Sun, 中国癌症研究（英文版） . 2011 ,第002期
4. Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy [O] . Zhenshu Xu, Shundong Cang, Ting Yang, 2009

机译：Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy

Cost-Effectiveness of First-Line Tyrosine Kinase Inhibitor Therapy Initiation Strategies for Chronic Myeloid Leukemia (vol 23, pg 1292, 2020)

著录项

相似文献

相关主题

期刊订阅